Below are the most recent publications written about "Muscles" by people in Profiles.
-
Poor AE, Zoga AC, Warren A, Waters LC, Vilotti L, Bentz GP, Meyers WC. Heterotopic Ossification and Platelet-Rich Plasma in Core Muscle Injuries: A Single-Institution Experience Over 6 Years. Am J Sports Med. 2024 Jan; 52(1):54-59.
-
Hlatky MA, Gonzalez PE, Manson JE, Buring JE, Lee IM, Cook NR, Mora S, Bubes V, Stone NJ. Statin-Associated Muscle Symptoms Among New Statin Users Randomly Assigned to Vitamin D or Placebo. JAMA Cardiol. 2023 Jan 01; 8(1):74-80.
-
Magliocco AM, Moughan J, Miyamoto DT, Simko J, Shipley WU, Gray PJ, Hagan MP, Parliament M, Tester WJ, Zietman AL, McCarthy S, Saeed-Vafa D, Xiong Y, Ayral T, Hartford AC, Patel A, Rosenthal SA, Chafe S, Greenberg R, Schwartz MA, Augspurger ME, Keech JA, Winter KA, Feng FY, Efstathiou JA. Analysis of MRE11 and Mortality Among Adults With Muscle-Invasive Bladder Cancer Managed With Trimodality Therapy. JAMA Netw Open. 2022 11 01; 5(11):e2242378.
-
Gonzalez PE, Hlatky MA, Manson JE, Buring JE, Lee IM, Cook NR, Bubes V, Stone NJ. Statin-associated muscle symptoms in the VITamin D and OmegA-3 TriaL (VITAL). Am Heart J. 2022 10; 252:39-41.
-
Dalakas MC. Complement in autoimmune inflammatory myopathies, the role of myositis-associated antibodies, COVID-19 associations, and muscle amyloid deposits. Expert Rev Clin Immunol. 2022 04; 18(4):413-423.
-
Hertz DL, Chen L, Henry NL, Griggs JJ, Hayes DF, Derstine BA, Su GL, Wang SC, Pai MP. Muscle mass affects paclitaxel systemic exposure and may inform personalized paclitaxel dosing. Br J Clin Pharmacol. 2022 07; 88(7):3222-3229.
-
Dalakas MC. Unconvincing Evidence of SARS-CoV-2-Associated Myositis in Autopsied Muscles. JAMA Neurol. 2022 01 01; 79(1):92.
-
Nozawa N, Noguchi M, Shinno K, Tajima M, Aizawa S, Saito T, Asada A, Ishii T, Ishizuka M, Iijima KM, Ando K. 5-Aminolevulinic acid and sodium ferrous citrate ameliorate muscle aging and extend healthspan in Drosophila. FEBS Open Bio. 2022 01; 12(1):295-305.
-
Pinter ZW, Wagner SC, Sebastian AS. Reply to the Letter to the Editor: Cervical Paraspinal Muscle Fatty Degeneration is Not Associated with Muscle Cross-sectional Area: Qualitative Assessment is Preferable for Cervical Sarcopenia. Clin Orthop Relat Res. 2021 08 01; 479(8):1860-1861.
-
Bellmunt J, Hussain M, Gschwend JE, Albers P, Oudard S, Castellano D, Daneshmand S, Nishiyama H, Majchrowicz M, Degaonkar V, Shi Y, Mariathasan S, Grivas P, Drakaki A, O'Donnell PH, Rosenberg JE, Geynisman DM, Petrylak DP, Hoffman-Censits J, Bedke J, Kalebasty AR, Zakharia Y, van der Heijden MS, Sternberg CN, Davarpanah NN, Powles T. Adjuvant atezolizumab versus observation in muscle-invasive urothelial carcinoma (IMvigor010): a multicentre, open-label, randomised, phase 3 trial. Lancet Oncol. 2021 04; 22(4):525-537.